TALS Talaris Therapeutics Inc

Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders, today announced that members of its senior management team will participate in the following investor conferences:

Morgan Stanley 20th Annual Global Healthcare ConferenceFireside chat date: Monday, September 12, 2022Fireside chat time: 1:40 p.m. ETLocation: Sheraton Hotel, New York, NY

H.C. Wainwright 24th Annual Global Investment Conference Presentation date: Wednesday, September 14, 2022Presentation time: 9:00 a.m. ETLocation: Lotte New York Palace Hotel, New York, NY

A live webcast of the presentations will be available on the investors section of the Talaris website at www.talaristx.com. After the live webcast, a replay of the events can be found on the Talaris website.

About Talaris TherapeuticsTalaris Therapeutics, Inc. is a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation and severe immune and blood disorders. Talaris maintains corporate offices in Boston, MA, its cell processing facility in Louisville, KY, and additional research operations in Houston, TX.

Media ContactLisa RaffenspergerTen Bridge Communicationslisa@tenbridgecommunications.com(617) 903-8783

Investor ContactChris BrinzeyICR Westwickechris.brinzey@westwicke.com (339) 970-2843